Charles R. Kummeth - Aug 7, 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact
Stock symbol
TECH
Transactions as of
Aug 7, 2022
Transactions value $
-$4,425,984
Form type
4
Date filed
8/9/2022, 06:58 PM
Previous filing
Aug 1, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +16.9K +7.2% $0.00 252K Aug 7, 2022 Direct F1
transaction TECH Common Stock Tax liability -$4.43M -11.6K -4.59% $382.97 240K Aug 7, 2022 Direct F1
holding TECH Common Stock 100 Aug 7, 2022 By Step-Son
holding TECH Common Stock 100 Aug 7, 2022 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -16.9K -100% $0.00* 0 Aug 7, 2022 Common Stock 16.9K Direct F3, F4
holding TECH Stock Options (Right to Buy) 256K Aug 7, 2022 Common Stock 256K $106.59 Direct F2
holding TECH Stock Options (Right to Buy) 195K Aug 7, 2022 Common Stock 195K $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 90.3K Aug 7, 2022 Common Stock 90.3K $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 60.2K Aug 7, 2022 Common Stock 60.2K $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 85.7K Aug 7, 2022 Common Stock 85.7K $190.41 Direct F2
holding TECH Stock Options (Right to Buy) 57.2K Aug 7, 2022 Common Stock 57.2K $190.41 Direct F5
holding TECH Restricted Stock Units 12.9K Aug 7, 2022 Common Stock 12.9K Direct F3, F6
holding TECH Stock Options (Right to Buy) 57.4K Aug 7, 2022 Common Stock 57.4K $267.87 Direct F6
holding TECH Stock Options (Right to Buy) 38.3K Aug 7, 2022 Common Stock 38.3K $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 16.7K Aug 7, 2022 Common Stock 16.7K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 16.7K Aug 7, 2022 Common Stock 16.7K $267.87 Direct F9
holding TECH Restricted Stock Units 8.02K Aug 7, 2022 Common Stock 8.02K Direct F3, F10
holding TECH Stock Options (Right to Buy) 31.3K Aug 7, 2022 Common Stock 31.3K $481.82 Direct F10
holding TECH Stock Options (Right to Buy) 20.9K Aug 7, 2022 Common Stock 20.9K $481.82 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs.
F5 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F6 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F8 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F9 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F10 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11 Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.